SEC Tracker
Get the app

Tvardi Therapeutics TVRD

Cara Therapeutics Reports First Quarter 2023 Financial Results

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Tvardi Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  2. Rocket Pharmaceuticals RCKT public float $213M, Jun 30, 2025
  3. Perspective Therapeutics CATX public float $213M, Jun 30, 2025
  4. SELLAS Life Sciences Group SLS public float $219M, Jun 30, 2025
  5. Precigen PGEN public float $219M, Jun 30, 2025